Greenberg Jason W, Morales David L S, Ahmed Hosam F, Desai Mallika V, Riggs Kyle W, Hayes Don, Lehenbauer David G, Hossain Md M, Zafar Farhan
The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio..
The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Semin Thorac Cardiovasc Surg. 2024 Winter;36(4):435-444. doi: 10.1053/j.semtcvs.2022.11.001. Epub 2022 Nov 7.
The demand for organs for lung transplantation (LTx) continues to outweigh supply. However, nearly 75% of donor lungs are never transplanted. LTx offer acceptance practices and the effects on waitlist/post-transplant outcomes by candidate clinical acuity are understudied. UNOS was used to identify all LTx candidates, donors, and offers from 2005 to 2019. Candidates were grouped by Lung Allocation Score (LAS; applicable post-2005, ages ≥12 years): LAS<40, 40-60, 61-80, and >80. Offer acceptance patterns, waitlist death/decompensation, and post-transplant survival (PTS) were compared. "Acceptable organ offers" were those from donors whose organs were accepted for transplantation. Approximately 3 million offers to 34,531 candidates were reviewed. Median waitlist durations were: 9 days-(LAS>80), 17 days-(LAS 61-80), 42 days-(LAS 40-60), 125 days-(LAS<40) (P < 0.001 between all). Per waitlist-day, offer rates were: total offers - 0.8/day-(LAS>80), 0.7/day-(LAS 61-80), 0.6/day-(LAS 40-60), 0.4/day-(LAS<40); acceptable offers - 0.34/day-(LAS>80), 0.32/day-(LAS 61-80), 0.24/day-(LAS 40-60), 0.15/day-(LAS<40) (both P < 0.001 between all LAS). Among patients who experienced waitlist mortality/decompensation, ≥1 acceptable offer was declined in 92% (3939/4270) of patients - 78% for LAS >80, 88% for LAS 61-80, 93% for LAS 40-60, and 96% for LAS <40. Thirty-day waitlist mortality/decompensation rates were: 46%-(LAS>80), 24%-(LAS 61-80), 5%-(LAS 40-60), <1%-(LAS<40) (P < 0.001 between all). PTS was equivalent between patients for whom the first/second offer vs later offers were accepted (all LAS P > 0.4). The first offers that LTx candidates receive (including acceptable organs) are declined for nearly all candidates. Healthier candidates can afford offer selectivity but more ill patients (LAS>60) cannot, experiencing exceedingly high 30-day waitlist mortality.
肺移植(LTx)对器官的需求持续大于供应。然而,近75%的供体肺从未被移植。LTx供肺接受情况以及候选者临床严重程度对等待名单/移植后结果的影响尚未得到充分研究。利用器官共享联合网络(UNOS)识别2005年至2019年期间所有的LTx候选者、供体和供肺。候选者根据肺分配评分(LAS;2005年后适用,年龄≥12岁)分组:LAS<40、40 - 60、61 - 80和>80。比较供肺接受模式、等待名单上的死亡/失代偿情况以及移植后生存率(PTS)。“可接受的器官供肺”是指其器官被接受用于移植的供体所提供的供肺。共审查了向34531名候选者发出的约300万次供肺。等待名单的中位时长分别为:9天 - (LAS>80)、17天 - (LAS 61 - 80)、42天 - (LAS 40 - 60)、125天 - (LAS<40)(所有组之间P<0.001)。按等待名单每日计算,供肺提供率分别为:总供肺 - 0.8次/天 - (LAS>80)、0.7次/天 - (LAS 61 - 80)、0.6次/天 - (LAS 40 - 60)、0.4次/天 - (LAS<40);可接受的供肺 - 0.34次/天 - (LAS>80)、0.32次/天 - (LAS 61 - 80)、0.24次/天 - (LAS 40 - 60)、0.15次/天 - (LAS<40)(所有LAS组之间均P<0.001)。在经历等待名单死亡/失代偿的患者中,92%(3939/4270)的患者拒绝了≥1次可接受的供肺 - LAS>80的患者为78%,LAS 61 - 80的患者为88%,LAS 40 - 60的患者为93%,LAS<40的患者为96%。30天等待名单死亡/失代偿率分别为:46% - (LAS>80)、24% - (LAS 61 - 80)、5% - (LAS 40 - 60)、<1% - (LAS<40)(所有组之间P<0.001)。首次/第二次供肺与后续供肺被接受的患者之间的PTS相当(所有LAS组P>0.4)。几乎所有LTx候选者都拒绝了他们收到的首次供肺(包括可接受的器官)。健康状况较好的候选者能够选择接受供肺,但病情较重的患者(LAS>60)则无法做到,他们在等待名单上30天的死亡率极高。